SAN DIEGO & SAN FRANCISCO, December 16, 2024--(BUSINESS WIRE)--Candid Therapeutics, Inc. ("Candid"), a clinical stage biotechnology company positioned to lead the development of T cell engagers for ...
Candid Therapeutics, a new San Diego biotech bent on becoming a leader in the emerging T-cell engager space, has unwrapped three new research collaborations focusing on autoimmune diseases. The EpimAb ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Lucia Moses Every time Lucia publishes a story, you’ll get an alert straight to your inbox!
DAEJEON, South Korea, and HAYWARD, Calif., Oct. 14, 2021 /PRNewswire/ -- IntoCell, a South Korean biotech developing novel antibody drug conjugate (ADC) platform technologies, today announced the ...
Asked to create a design reflecting modernism with an eco-friendly approach, AB extended the home in various directions, incorporating rectilinear volumes and elevated outdoor spaces. With a starting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback